Genital Human Papillomavirus Infection: Incidence and Risk Factors in a Cohort of Female University Students R.L. Winer, Shu-Kuang Lee, J.P. Hughes, D.

Slides:



Advertisements
Similar presentations
HPV 101.
Advertisements

Issues in Genital Herpes
How to Measure the Effectiveness of the IPP (and all the CT Screening being done)? **Reduce Infertility** Ultimate Goal Reduce PID Reduce Chlamydia Prevalence.
Persistence of HPV in a cohort of female adolescents Erika Samoff, Emilia H. Koumans, Lauri E. Markowitz, Maya Sternberg, Mary K. Sawyer, David Swan, John.
Case-Control Studies (Retrospective Studies). What is a cohort?
Journal Club Alcohol, Other Drugs, and Health: Current Evidence July–August 2013.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence July–August 2008.
Curable versus incurable STDs. Objectives To describe the natural history and epidemiology of two curable STDs (i.e. syphilis and chlamydia) and two non-
STD Surveillance 2001 Adapted from CDC by Jill Gallin, CPNP Assistant Professor of Clinical Nursing.
Dr. Rufaidah Dabbagh Dr. Armen Torchyan MBBS, MPH MD, MPH CMED 304 Family and Community Medicine Department Family and Community Medicine Department.
Spotlight on Cervical Cancer Screening
Journal Club Alcohol, Other Drugs, and Health: Current Evidence May-June 2008.
The HPV Vaccine Our Best Shot to Prevent Cervical Cancer Harold C. Wiesenfeld, MD,CM Department of Obstetrics, Gynecology and Reproductive Sciences-University.
Cervical Cancer and HPV
Human Papillomavirus and Cervical Cancer And ways to prevent it! Lindsey Saunders Auburn University NURS 7446 December 3, 2014.
Preventive Care and Sexual Health Information for Tweens and Teens
Anticipated impact on HPV infection from HPV vaccination programs – cause for optimism Dr Paddy Horner.
Interim Guidance for the Use of Human Papillomavirus DNA Testing as an Adjunct to Cervical Cytology for Screening Obstetrics and Gynecology, Volume 103,
Combined Oral Contraceptive Pills (COCs)
Manish Chaudhary BPH, MPH
Human Papillomavirus (HPV)
Risk factors for Incident Trichomonas vaginalis among Women Recruited in RESPECT-2, an HIV Prevention Trial D Helms 1, D Mosure 1, T Peterman 1, C Metcalf.
Patterns of Age Mixing and Sexually Transmitted Infections Julie Kraut-Becher University of Pennsylvania Sevgi O. Aral Division of STD Prevention, CDC.
Glucose Levels and Risk of Dementia Presented by - Anas Kabaha, MD Sheba medical center Sheba medical center August 8,2013.
Lecture 8 Objective 20. Describe the elements of design of observational studies: case reports/series.
Case-Control Study of Human Papillomavirus and Oropharyngeal Cancer Osler Journal Club Shaline Rao, MD June 10, 2009.
Condom Use Questions as Predictors of Urogenital Gonorrhea Adrianne M. Williams, MD, Philana Liang, PA-C, MPH, Renee M. Gindi, MPH, Khalil G. Ghanem, MD,
What Is HPV? Human Papillomaviruses have an icosahedral shape, contain DNA, and are non-enveloped There are at least 100 different types of HPV Over 30.
Epidemiology of a Chronic Disease Exercise By Mary Murphy April 2008
HPV Related Disease Ginny Ryan. What Is HPV? The human papillomavirus is the most common sexually transmitted infection in the U.S. – 79 million Americans.
Faiza Ali MD, Ericka Hayes MD, Gaurav Kaushik MPH, Nicole Carr RN, Katie Plax MD Washington University School Of Medicine Department of Pediatrics.
Chapter 13 pages Personal Wellness Sexually Transmitted Diseases.
PREDICTORS OF PAP SCREENING RATES AMONG FEMALE UNIVERSITY STUDENTS IN MARITIME CANADA A. STEENBEEK 1,2, A. CRAGG 2, M. ASBRIDGE 2, P. ANDREOU 2 & D. LANGILLE.
Herpes Papillomavirus (HPV) and Varicella-zoster Virus (VZV) Vaccination Ellen Barbouche, MD Primary Care Conference 18 April 2007.
TEMPLATE DESIGN © Study on Risk Factors for Cervical Carcinoma at Central Women’s Hospital, Yangon Muyar Soe, Myat Thazin.
1 Ch. 21. Health and Medicine Medical Sociology. 2 Today’s coming attractions !!  How does culture shape your health?  What are you most likely to die.
Factors associated with abnormal PAP Smears in a health center X – Costa Rica, 2009 Leandra Abarca 1, Julia Freer 1, Maricela Salas 2 1, MD, MsC, FETP,
Literature searching & critical appraisal Chihaya Koriyama August 15, 2011 (Lecture 2)
National Center for Health Statistics DCC CENTERS FOR DISEASE CONTROL AND PREVENTION Women’s Health Data in the National Survey of Family Growth (NSFG)
1 Ch. 21. Health and Medicine Medical Sociology. Two states comparison 2.
Case-control study Chihaya Koriyama August 17 (Lecture 1)
EFFICACY OF A STAGE-BASED BEHAVIORAL INTERVENTION TO PROMOTE STI SCREENING IN YOUNG WOMEN: A RANDOMIZED CONTROLLED TRIAL Chacko MR, Wiemann CM, Kozinetz.
Nies and Nies and McEwen: Chapter 4: ATI: Chapter 3 Epidemiology.
The Relationship Between Knowledge and Beliefs About Human Papillomavirus, Acceptance of the Human Papillomavirus Vaccine, and Intentions to Practice Safer.
BISEXUAL CONCURRENCY,BISEXUAL PARTNESHIPS,AND HIV AMONG SOUTHERN AFRICA MEN WHO HAVE SEX WITH MEN (MSM) Presenter: Gift Trapence Organisation: Centre for.
Providing Treatment, Restoring Hope Secondary Prevention as part of HIV Clinical Care Martine Etienne, MPH, DrPH University of Maryland School of Medicine.
STIs (sexually transmitted infections) in the geriatric population
Epidemiological Research. Epidemiology A branch of medical science that deals with the incidence, distribution, and control of disease in a population.
1 CONFIDENTIAL – DO NOT DISTRIBUTE ARIES mCRC: Effectiveness and Safety of 1st- and 2nd-line Bevacizumab Treatment in Elderly Patients Mark Kozloff, MD.
Screening of genital cancers Evidence Based Presented by Dr\ Heba Nour.
Chapter 13 Personal Wellness Sexually Transmitted Diseases Pages
NHS Cervical Screening Programme Introducing HPV triage and test of cure.
Results from the STEAM Survey Elizabeth Barash, MPH.
NAAT identified chlamydial infections: Enhanced sensitivity, reduced transmissibility? Presenter: Maria Villarroel, MA Authors: Maria A. Villarroel, MA.
Effect of ART on malaria parasitaemia and clinical episodes in adults in rural Uganda: A population-based cohort study Billy N. Mayanja 1, Kathy Baisley.
HIV Prevalence and Incidence Estimates Among Women with High Risk Indicators in Addis Ababa, Ethiopia Asfawesen G-Yohanes 1, Stephanie Combes 2, Abraham.
Associations Between Recent Gender- Based Violence and Pregnancy, Sexually Transmitted Infections, Condom Use Practices, and Negotiation of Sexual Practices.
Cervical Cancer Awareness: HPV 101
Seeking HIV-testing Only: Missed Opportunity for HIV Prevention?
Seroprevalence, prevalence, type and factors associated with HPV infection at multiple sites in young HIV-positive MSM On behalf of the HPV MAPS Research.
1University of Kentucky, Lexington, Kentucky
Please go to: polleverywhere
Human Papillomavirus (HPV)
Ch. 21. Health and Medicine Medical Sociology.
A study of high risk African American women, 15 to 21 years of age
Risks for Bacterial Vaginosis in Lesbian & Bisexual Women
SEXUAL RISK BEHAVIOR OF PLWHA IN THE WA MUNICIPALITY
Sexually Transmitted Infections (STIs) in Ireland, 2016
PrEP and Condom Use Keri Broadley and John Del Gaizo.
Share your thoughts on this presentation with #IAS2019
Presentation transcript:

Genital Human Papillomavirus Infection: Incidence and Risk Factors in a Cohort of Female University Students R.L. Winer, Shu-Kuang Lee, J.P. Hughes, D. E. Adam, N.B. Kiviat, L.A. Koutsky American Journal of Epidemiology, 2003:157(3) Presented by Patrick Heyman Palm Beach Atlantic University

Background ● Human Papillomavirus (HPV)  Most prevalent STI ~50% of women  Some strains cause genital/anal warts  Some strains cause cervical cancer  Good incidence data is not available  Risk factors are largely unknown

Research Objectives ● Determine the cumulative incidence of HPV infection in a group of female university students ● Study the relationship of various characteristics on HPV infection in women

Methods ● Recruitment  1990 to 1997  Letters sent to a “Random sample” of students  Eligible women (Washington residents, planned to stay for three years)  603 women recruited out of ~3000 eligible women

Methods ● Initial visit  Medical and sexual history, social history ● Subjects saw nurse practitioner every 4 months  Face-to-face interview  Standardized pelvic examination ● Updated behavioral and medical information ● New sex partners ● Separate cervical and vulvovaginal swabs sent for HPV DNA tests ● Saliva tests sent for HPV DNA tests

Methods ● Response variable  HPV DNA: yes/no ● Generic probe ● HPV Types (Strain)  Time until infection ● Previously sexually active: from enrollment date ● Virgins: from first sexual encounter

Results ● 553 enrolled women with adequate samples ● 109 (19.7 percent) had HPV DNA at first visit ● 444 HPV-DNA negative at enrollment  4,307 total visits  41.2 (st dev 16.3) months follow-up  9.7 (st dev 3.4) visits per person  4.3 months median time between visits  19.2 (st dev 0.5) years, mean age at enrollment  148 virgins, 94 became sexually active  1.8 (st dev 1.7) mean lifetime number of partners

Cumulative 24 month Incidence ● Sexually active at enrollment  38.8% (95% CI, 33.3% %) ● Virgins who initiated sexual activity  38.9% (95% CI, 29.4 – 50.3) ● Vulvovaginal swabs + before cervical swabs ● No difference  Between years (p = 0.53)  Virgins vs already sexually active (p = 0.35)  0, 1-2, 3 partners at enrollment (p = 0.28) ● Oral: 5/2500 samples

Cumulative Incidence of HPV Among Sexually Active Women Cumulative incidence of human papillomavirus (HPV) infection among women sexually active and HPV negative at enrollment (n = 296) in Washington State, 1990?2000. Vertical bars, 95% confidence intervals at 12, 24, 36, 48, and 60 months.

Cumulative Incidence of HPV Among Virgins at Enrollment

HR after Acquisition of a New Partner

Potential Risk Factors

Other Risk Factors ● Non-pentrative sex for virgins  9.7% vs. 1.3% ● Non risk factors  Partner's (age, race, educational level, circumcision status, sexually transmitted disease history)  Partnership (condom use and alcohol consumption)  Tampon use  Cesarean delivery  Nongenital warts

HPV Types

Discussion ● End prevalence was similar to three other studies done in young women ● Risk after new partner similar to risk for virgins who became sexually active ● Risk is greatest 5 – 8 months after acquiring a new partner ● Risk decreases after 13 months ● Vulvovaginal swabs may be more sensitive

Discussion ● Smoking was associated with increased risk even after adjusting for other risk factors  Most other studies do not show a link between smoking and risk for HPV  Perhaps some confounding sexual behavior  Perhaps current smoking is the key, and the visits every four months were more accurate in recording smoking ● Oral contraceptives were associated with increased risk, unlike other studies

Discussion ● Condoms showed no reduction in risk consistent with six other studies ● HPV is transmissible by non-penetrative sex ● A very small percentage of non-sexually active have HPV (<2%) in accordance with other studies ● Oral-penile sex was frequent, but oral HPV low  Oral HPV infection is low  Or Test to detect it is not sensitive enough

Limitations ● Only 20% of recruited women participated ● Comparative studies are often clinic based, which show higher infection rates ● Unable to “capture all forms of non-penetrative sex” ● Reporting bias ● Recall bias (four month intervals) ● Unable to capture frequency of sexual exposures or concurrent partners

Limitations ● HPV DNA testing methods are much better now ● Cohort may not generalize to other populations  Regional bias  Healthy, young, university females ● Older ● Immunocompromised ● Higher partner change

Conclusion/Implications for Practice ● New partners increase risk of HPV infection ● Not knowing your partner's sexual history increases risk ● 0 – 12 months after new partner acquisition is the key screening period ● Virgins can have HPV ● Non-penetrative sex can lead to infection